mirabegron 8 MG/mL 24HR Extended Release Suspension

RxCUI: 2541233
RxNorm name: mirabegron 8 MG/mL 24HR Extended Release Suspension
Display name: mirabegron 8 MG/mL 24HR Extended Release Suspension
Full name: mirabegron 8 MG/mL 24HR Extended Release Suspension
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:18

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Mirabegron	MIRABEGRON	Ascend Laboratories, LLC	1c9022af-4841-4f3f-9737-1c5eef58e86b	2026-05-22	Warnings, Adverse reactions	Exact identifier rxcui: 2541233
Myrbetriq	MIRABEGRON	Astellas Pharma US, Inc.	ba9e9e15-e666-4c56-9271-2e24739cfa2d	2024-08-01	Warnings, Adverse reactions	Exact identifier rxcui: 2541233

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
ba9e9e15-e666-4c56-9271-2e24739cfa2d	mirabegron 8 MG/mL 24HR Extended Release Suspension [PSN] · 24 HR mirabegron 8 MG/ML Extended Release Suspension [SCD] · mirabegron 8 MG/ML 24 HR Extended Release Suspension [SY]	3	17	These highlights do not include all the information needed to use MYRBETRIQ ® /MYRBETRIQ ® GRANULES safely and effectively. See full prescribing information for MYRBETRIQ/MYRBETRIQ GRANULES. MYRBETRIQ (mirabegron extended-release tablets), for oral use MYRBETRIQ GRANULES (mirabegron for extended-release oral suspension) Initial U.S. Approval: 2012	20240801
1c9022af-4841-4f3f-9737-1c5eef58e86b	mirabegron 8 MG/mL 24HR Extended Release Suspension [PSN] · 24 HR mirabegron 8 MG/ML Extended Release Suspension [SCD] · mirabegron 8 MG/ML 24 HR Extended Release Suspension [SY]	3	6	These highlights do not include all the information needed to use MIRABEGRON FOR EXTENDED-RELEASE ORAL SUSPENSION safely and effectively. See full prescribing information for MIRABEGRON FOR EXTENDED-RELEASE ORAL SUSPENSION. MIRABEGRON for extended-release oral suspension Initial U.S. Approval: 2012	20260318